Marksans Pharma Ltd. — Capital/Financing Update 2021

Jun 18, 2021

·_. Marksans Pharma Ltd.

National Stock Exchange of India Limited

Listing Department Exchange Plaza, C-l, Block -G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

This is with reference to the Exchange's e-mail communication dated 17[th] June, 2021 regarding amendment to Articles of Association of the Company. In this connection, we would like to state as under.

In connection with an offer of OrbiMed Asia IV Mauritius FVCI Limited ("OrbiMed) to the Company to participate in the issue of convertible walTants on preferential basis, OrbiMed and the Company will enter into a Warrant Subscription Agreement approved by the Board of Directors in its meeting held on 15[th] June, 2021. One ofthe,condition ofthe said offer is that the Articles of Association ofthe Company be amended • to include the provisions of the Warrant Subscription Agreement.

In view thereof, the current set of Articles of Association of the Company need to be amended and restated to incorporate the provisions of the above Warrant Subscription Agreement.

Yours faithfully,

For Marksans Pharma Limited

jQJJMs!i-- Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

11 th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Des,ai.Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: Info@marksanspharma.com www.marksanspharma.com